Beta Bionics Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
BBNX$16.95+8.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | Description of Exhibit | Form | File No. | Exhibit | Filing Date | Filed Herewith |
|---|---|---|---|---|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant. | 8-K | 001-42491 | 3.1 | 01/31/25 | |
| 3.2 | Amended and Restated Bylaws of the Registrant. | S-1 | 333-284147 | 3.4 | 01/06/25 | |
| 4.1 | Form of Common Stock Certificate. | S-1/A | 333-284147 | 4.1 | 01/22/25 | |
| 4.2 | Amended and Restated Investor Rights Agreement, dated November 8, 2024, by and among the Registrant and certain of its stockholders. | S-1 | 333-284147 | 4.2 | 01/06/25 | |
| 10.1* | Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers. | S-1 | 333-284147 | 10.1 | 01/06/25 | |
| 10.2* | Beta Bionics, Inc. 2025 Equity Incentive Plan. | S-1/A | 333-284147 | 10.4 | 01/22/25 | |
| 10.3* | Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Beta Bionics, Inc. 2025 Equity Incentive Plan. | S-1 | 333-284147 | 10.5 | 01/06/25 | |
| 10.4* | Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Beta Bionics, Inc. 2025 Equity Incentive Plan. | S-1 | 333-284147 | 10.6 | 01/06/25 | |
| 10.5* | Forms of Stock Option Grant Double Trigger Grant Notice and Award Agreement under the Beta Bionics, Inc. 2025 Equity Incentive Plan | S-1/A | 333-284147 | 10.7 | 01/22/25 | |
| 10.6* | Forms of Restricted Stock Unit Double Trigger Grant Notice and Award Agreement under the Beta Bionics, Inc. 2025 Equity Incentive Plan. | S-1/A | 333-284147 | 10.8 | 01/22/25 | |
| 10.7* | Beta Bionics, Inc. 2025 Employee Stock Purchase Plan. | S-1/A | 333-284147 | 10.9 | 01/22/25 | |
| 10.8* | Non-Employee Director Compensation Policy. | S-1/A | 333-284147 | 10.10 | 01/22/25 | |
| 10.9 | Common Stock Purchase Agreement, dated as of January 21, 2025, by and between Wellington Hadley Harbor Aggregator IV, L.P. and the Registrant. | S-1/A | 333-284147 | 10.23 | 01/22/25 | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2* | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.1*+ | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 101.INS | Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | ||||
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | X | ||||
- Indicates a management contract or any compensatory plan, contract or arrangement.
- The certification furnished in Exhibit 32.1 hereto is deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certification will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.